skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Management of myasthenia gravis during pregnancy

Indian journal of pharmacology, 2018-11, Vol.50 (6), p.302-308 [Peer Reviewed Journal]

COPYRIGHT 2018 Medknow Publications and Media Pvt. Ltd. ;2018. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2019 Indian Journal of Pharmacology 2019 ;ISSN: 0253-7613 ;EISSN: 1998-3751 ;DOI: 10.4103/ijp.IJP_452_17 ;PMID: 30783322

Full text available

  • Title:
    Management of myasthenia gravis during pregnancy
  • Author: Bansal, Ramandeep ; Goyal, Manoj ; Modi, Manish
  • Subjects: Breastfeeding & lactation ; Care and treatment ; Childbirth & labor ; Drug dosages ; Educational Forum ; Immunoglobulins ; Maternal mortality ; Mothers ; Myasthenia gravis ; Pregnancy ; Pregnant women
  • Is Part Of: Indian journal of pharmacology, 2018-11, Vol.50 (6), p.302-308
  • Description: The management of myasthenia gravis (MG) during pregnancy requires special skills as both diseases as well as its treatment can have deleterious effects on mother and fetus. MG often affects women in second and third decades of life during the childbearing age. Exacerbations of MG are likely to occur during the first trimester and postpartum period. The treatment of MG during pregnancy needs to be individualized depending on the severity of MG as well as the efficacy of various treatment modalities and their possible harmful effects on pregnancy. In addition, special attention has to be given to avoid drugs and other factors (such as urinary tract infections) which may worsen MG. The key to successful outcome during pregnancy in myasthenic women lies in multidisciplinary care involving obstetricians, neurologists, anesthetist as well as neonatologist. In this review, we discuss various therapeutic options available for the management of MG during pregnancy and provide recommendations based on the current best evidence.
  • Publisher: India: Wolters Kluwer India Pvt. Ltd
  • Language: English
  • Identifier: ISSN: 0253-7613
    EISSN: 1998-3751
    DOI: 10.4103/ijp.IJP_452_17
    PMID: 30783322
  • Source: GFMER Free Medical Journals
    PubMed Central
    Alma/SFX Local Collection
    ProQuest Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait